标题
RNA therapeutics in ophthalmology - translation to clinical trials
作者
关键词
siRNA, Antisense oligonucleotide, Clinical trial, Glaucoma, Macular degeneration, Inherited retinal disorders
出版物
EXPERIMENTAL EYE RESEARCH
Volume 205, Issue -, Pages 108482
出版商
Elsevier BV
发表日期
2021-02-04
DOI
10.1016/j.exer.2021.108482
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy
- (2020) Kasia Dzierlega et al. GENE THERAPY
- The powerful world of antisense oligonucleotides: From bench to bedside
- (2020) Anaïs M. Quemener et al. Wiley Interdisciplinary Reviews-RNA
- Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases
- (2020) Kanmin Xue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
- (2020) Karishma Dhuri et al. Journal of Clinical Medicine
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Leber Congenital Amaurosis Associated with Mutations in CEP290 , Clinical Phenotype, and Natural History in Preparation for Trials of Novel Therapies
- (2018) Leo Sheck et al. OPHTHALMOLOGY
- The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy
- (2018) Dimitra Athanasiou et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Special Issue Introduction: Inherited Retinal Disease: Novel Candidate Genes, Genotype–Phenotype Correlations, and Inheritance Models
- (2018) Frans Cremers et al. Genes
- Development of targeted siRNA nanocomplexes to prevent fibrosis in experimental glaucoma filtration surgery
- (2018) Owen Fernando et al. MOLECULAR THERAPY
- Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 Models
- (2018) Kalyan Dulla et al. Molecular Therapy-Nucleic Acids
- Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect
- (2018) Artur V. Cideciyan et al. NATURE MEDICINE
- Antisense oligonucleotides: the next frontier for treatment of neurological disorders
- (2017) Carlo Rinaldi et al. Nature Reviews Neurology
- The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market
- (2017) Ricardo Titze-de-Almeida et al. PHARMACEUTICAL RESEARCH
- First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
- (2017) Norbert Pfeiffer et al. PLoS One
- Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease: A Multicenter Randomized Trial
- (2016) Andrea Leonardi et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Receptor-targeted liposome-peptide-siRNA nanoparticles represent an efficient delivery system for MRTF silencing in conjunctival fibrosis
- (2016) Cynthia Yu-Wai-Man et al. Scientific Reports
- Viral Vectors for Gene Therapy: Translational and Clinical Outlook
- (2015) Melissa A. Kotterman et al. Annual Review of Biomedical Engineering
- Usher syndrome: Hearing loss, retinal degeneration and associated abnormalities
- (2015) Pranav Mathur et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Review and update on the molecular basis of Leber congenital amaurosis
- (2015) Oscar Francisco Chacon-Camacho World Journal of Clinical Cases
- The effect of the common c.2299delG mutation in USH2A on RNA splicing
- (2014) Eva Lenassi et al. EXPERIMENTAL EYE RESEARCH
- Geographic Atrophy
- (2014) Frank G. Holz et al. OPHTHALMOLOGY
- Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy
- (2013) A Guzman-Aranguez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mitomycin C versus5-fluorouracil as an adjunctive treatment for trabeculectomy: a meta-analysis of randomized clinical trials
- (2013) Lígia I De Fendi et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Using the Early Postoperative Intraocular Pressure to Predict Pressure Control After a Trabeculectomy
- (2013) Satoshi Okimoto et al. JOURNAL OF GLAUCOMA
- Phase I Clinical Trial of SYL040012, a Small Interfering RNA Targeting β-Adrenergic Receptor 2, for Lowering Intraocular Pressure
- (2013) Javier Moreno-Montañés et al. MOLECULAR THERAPY
- Seven new loci associated with age-related macular degeneration
- (2013) Lars G Fritsche et al. NATURE GENETICS
- Phase 1 dose-escalation study of a siRNA targeting the RTP801 gene in age-related macular degeneration patients
- (2012) Q D Nguyen et al. EYE
- RNA therapeutics: beyond RNA interference and antisense oligonucleotides
- (2012) Ryszard Kole et al. NATURE REVIEWS DRUG DISCOVERY
- Evaluation of the siRNA PF-04523655 versus Ranibizumab for the Treatment of Neovascular Age-related Macular Degeneration (MONET Study)
- (2012) Quan Dong Nguyen et al. OPHTHALMOLOGY
- siRNA-optimized Modifications for Enhanced In Vivo Activity
- (2012) Denise M Kenski et al. Molecular Therapy-Nucleic Acids
- Silencing disease genes in the laboratory and the clinic
- (2011) Jonathan K Watts et al. JOURNAL OF PATHOLOGY
- High-Dose siRNAs Upregulate Mouse Eri-1 at both Transcription and Posttranscription Levels
- (2011) Yingnan Bian et al. PLoS One
- RNAi-Based Treatment for Neovascular Age-Related Macular Degeneration by Sirna-027
- (2010) Peter K. Kaiser et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- The pathogenic role of transforming growth factor-β2 in glaucomatous damage to the optic nerve head
- (2010) Rudolf Fuchshofer EXPERIMENTAL EYE RESEARCH
- Influence of Race and Age on Aqueous Humor Levels of Transforming Growth Factor-Beta 2 in Glaucomatous and Nonglaucomatous Eyes
- (2010) Rupal H. Trivedi et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
- (2010) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Factors Associated with Improvement and Worsening of Visual Acuity 2 Years after Focal/Grid Photocoagulation for Diabetic Macular Edema
- (2010) Lloyd Paul Aiello et al. OPHTHALMOLOGY
- Prevalence of Age-related Macular Degeneration in Old Persons: Age, Gene/Environment Susceptibility Reykjavik Study
- (2010) Fridbert Jonasson et al. OPHTHALMOLOGY
- Change in Area of Geographic Atrophy in the Age-Related Eye Disease Study
- (2009) ARCHIVES OF OPHTHALMOLOGY
- Origins and Mechanisms of miRNAs and siRNAs
- (2009) Richard W. Carthew et al. CELL
- The RNA-induced Silencing Complex: A Versatile Gene-silencing Machine
- (2009) Ashley J. Pratt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A three-dimensional view of the molecular machinery of RNA interference
- (2009) Martin Jinek et al. NATURE
- Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
- (2009) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth
- (2009) W. G. Cho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- COMBINATION THERAPY USING THE SMALL INTERFERING RNA BEVASIRANIB
- (2009) LAWRENCE SINGERMAN RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Delivery Vehicles for Small Interfering RNA In Vivo
- (2008) Antonin R. de Fougerolles HUMAN GENE THERAPY
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
- (2008) Mark E. Kleinman et al. NATURE
- Oxidative damage–induced inflammation initiates age-related macular degeneration
- (2008) Joe G Hollyfield et al. NATURE MEDICINE
- Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
- (2008) R. Juliano et al. NUCLEIC ACIDS RESEARCH
- Chemical Modification of siRNAs for In Vivo Use
- (2008) Mark A. Behlke OLIGONUCLEOTIDES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More